The MET Inhibitor ABN401 in Combination with the Third-Generation EGFR-TKI is Effective MET-Amplified and EGFR-Mutant NSCLC with Acquired Resistance to Third-Generation EGFR-TKI in Preclinical Models
ABN-401
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: The MET Inhibitor ABN401 in Combination with the Third-Generation EGFR-TKI is Effective MET-Amplified and EGFR-Mutant NSCLC with Acquired Resistance to Third-Generation EGFR-TKI in Preclinical Models ### Output: ABN-401